Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule with the molecular formula C22H20ClFN4O4S and a molecular weight of approximately 490.9 g/mol. It is listed in chemical and drug databases (CHEMBL561318; DrugBank DB07875), but there is no evidence it has been approved or marketed as a pharmaceutical product. The structure features a thiophene ring substituted with chlorine and carboxylic acid at the 5 and 2 positions respectively, linked via an amide bond to a chiral pyrrolidine moiety bearing additional functional groups including fluorinated phenyl and pyridone substituents. There are no published indications or clinical uses for this compound; it appears to be an experimental molecule possibly investigated for its biological activity or as part of medicinal chemistry research pipelines[6][8]. No specific mechanism of action or therapeutic target has been established in public sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide.